BRAFV600E mutation, TIMP-1 upregulation, and NF-κB activation: closing the loop on the papillary thyroid cancer trilogy

Alessandra Bommarito(University of Palermo), Carla Giordano(Istituto di Biomedicina e di Immunologia Molecolare Alberto Monroy)
Endocrine Related Cancer
September 8, 2011
10.1530/erc-11-0076
Cited by 69

Related Papers

<i>BRAF<sup>V600E</sup></i> mutation and p27<sup>kip1</sup> expression in papillary carcinomas of the thyroid ≤1 cm and their paired lymph node metastases
|Cancer|2007|78
BRAF mutation influences hypoxia-inducible factor-1α expression levels in papillary thyroid cancer
|Modern Pathology|2010|47
Predictive factors of polycystic ovary syndrome in girls with precocious pubarche
|Endocrine Connections|2021|9